Evaluation of Trigeminal Nerve Blockade

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

October 7, 2025

Study Completion Date

October 7, 2025

Conditions
Mouth AbnormalitiesCleft PalateBirth Defect
Interventions
DRUG

Ropivacaine

A single injection into the pterygopalatine fossa bilaterally of 0.2% ropivacaine at a dose of 0.15 mL/kg (block) after the induction of general anesthesia

OTHER

Sham Comparator

The subcutaneous placement of a 25 Gauge needle as a sham control after the induction of general anesthesia. Nothing will be injected.

Trial Locations (1)

32610-3003

UF Health, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER